Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

View:
Post by Thenorth1990 on Jul 02, 2021 6:42pm

Management

The guys on top are there for a reason, there is no point bashing them every now and then. For me personally their success was getting the guys from Boston before the biogen Judegment day and the gamble to align ourselves with aducanumab kind of paid off. I do hate the fact that they don't stick to the timeliness they provide and thankfully they have the forward looking statement disclosure to hide behind. -Waiting for an update on Serology , probably the most disappointing work yet by promis. We were all told that this would be ready by last summer and expected revenues q4 2020. I hope we had some way of keeping them accountable. We all know this has potential and now it's been validated. When this happens it will be huge for sure, but my hopes for some sp action happening this quarter is dead. Happy Weekend
Comment by Annayya on Jul 03, 2021 3:18am
We are into July, with the first half of 2021 done with no significant updates other than the Boston investment. Timelines is really what these people suck at. Being lazy is one thing, but they just don't get the work done and simply provide excuses for years and not even admitting clearly that they failed with their timelines again. You bring up a great recent example which is the serology ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities